ConductScience.org, home

Gene · 3549

NIH grants2,031

NIH grants whose papers are about the gene, through NIH's grant-paper links.

381 to 400 of 2,031

Download this page as JSON
GrantTitleIHH papersNewest fiscal year
P40OD010939Referral Ctr-Animal models of human genetic disease22023
R01AG056438Cbf mediates articular cartilage regeneration and repair in aging22023
R01AR062207The immunological mechanism of PGRNs anti-inflammatory effect22023
R01AR072500Mechanisms Mediating Osseointegration of 3D Printed Titanium Constructs22023
R01DK120689Role of ATG14 in the regulation of hepatic function22023
R01DK121925Epigenetic regulation in liver fibrosis22023
R21AG072288Role of SIRT6 in the pancreatic beta cell aging22023
T32AR007505Training Program in Musculoskeletal Research22023
U01DK103141Niche support of human intestinal stem cells22023
F30CA246808Investigating the Regulation and Role of FOXM1 in Aggressive Meningioma12023
F30CA265147Understanding Patched1 protein and lipid interactions in cilia12023
K00CA234940A mechanistic dissection of the role of Eya3 in breast cancer metastasis12023
K01DK120737Neuropathic vs. inflammatory pain in chronic pancreatitis: can unique biomarkers be identified to guide mechanistic approaches to pain treatment?12023
K08DK122114Mechanisms of extrahepatic biliary proliferation and regeneration12023
K08DK128585The Role Wnt Signaling in Biliary Homeostasis and Disease12023
K12HD051959Hormones and Genes in Women's Health: From Bench to Bedside12023
K23HL141667Investigating the role of mitochondria in thoracic aortic aneurysm pathogenesis12023
P01DK011794Hormonal Control of Calcium Metabolism12023
P01DK096990New Therapies for Liver Fibrosis and Hyperproliferation in Alpha1-AT Deficiency12023
P20GM103641Dietary Supplements and Inflammation Phase-2: Isoxanthohumol as a treatment for estrogen-deficient-induced visceral hyperalgesia.12023

Source NIH's project filesgene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3549/grants?page=20